Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

We investigated the value of susceptibility testing in predicting response in AIDS-associated cryptococcal meningitis using clinical isolates from a randomized controlled trial of antifungal treatment (amphotericin monotherapy, amphotericin with flucytosine, or amphotericin with fluconazole). We found no correlation between antifungal susceptibility and either early or late survival, or fungal clearance.

More information Original publication

DOI

10.1093/cid/ciaa1544

Type

Journal article

Publication Date

2021-10-01T00:00:00+00:00

Volume

73

Pages

e2338 - e2341

Addresses

G, u, y, ', s, , a, n, d, , S, t, , T, h, o, m, a, s, ', , N, H, S, , T, r, u, s, t, ,, , U, n, i, t, e, d, , K, i, n, g, d, o, m, .

Keywords

Humans, Meningitis, Cryptococcal, Acquired Immunodeficiency Syndrome, Fluconazole, Flucytosine, Antifungal Agents